Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors

被引:4
|
作者
Sun, Yaoyao [1 ,2 ]
Wang, Yueying [2 ]
Li, Rixin [2 ]
Kang, Guojun [2 ]
Zhang, Mingyuan [2 ]
Chen, Xin [2 ]
Jin, Mengdi [2 ]
Liu, Yang [2 ]
He, Yang [2 ]
Zhu, Xiaojing [2 ]
Kang, Qi [2 ]
Zhou, Fengfeng [1 ]
Yu, Qiong [1 ,2 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Canc Syst Biol Ctr, Changchun, Peoples R China
[2] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin, Peoples R China
关键词
Pancreatic neuroendocrine tumors; Survival analysis; Surgery; Low-grade;
D O I
10.1016/j.clinre.2020.04.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction. - The incidence of pancreatic neuroendocrine tumors (PNETs) is increasing over the past few decades. Surgery for low-grade and small PNETs of less than 2 cm and N0M0 is still debated. The purpose of this study is to examine the association between surgical resection and survival in patients with low-grade nonfunctioning PNETs. Materials and methods. - Patients diagnosed with PNETs between 2004 and 2015 were extracted from SEER. Kaplan-Meier methods and Cox proportional hazard models were used to estimate independent predictors in PNETs patients. Results. - A total of 2637 patients (2147 underwent surgical resection and 490 did not undergo surgery) with histologically confirmed low-grade PNETs in this cohort study. Overall survival (OS) and cancer-specific survival (CSS) of patients with surgery was better than those without surgery (log rank test POS < 0.001, PCSS < 0.001). Multivariate Cox regression analysis showed that surgical status was an independent prognostic factor associated with OS (HR 3.257, 95%CI: 2.635, 4.026) and CSS (HR 3.546, 95%CI: 2.798, 4.493). Subgroup analysis suggested the patients receiving surgery apparently had better OS and CSS regardless of tumor size (all log rank test POS < 0.001, all log rank test PCSS < 0.001) and SEER stage (all log rank test POS < 0.001, all log rank test PCSS < 0.001), compared to patients without removal of the primary tumor. <comment>Superscript/Subscript Available</comment> ABSTRACT Summary Introduction. - The incidence of pancreatic neuroendocrine tumors (PNETs) is increasing over the past few decades. Surgery for low-grade and small PNETs of less than 2 cm and N0M0 is still debated. The purpose of this study is to examine the association between surgical resection and survival in patients with low-grade nonfunctioning PNETs. Materials and methods. - Patients diagnosed with PNETs between 2004 and 2015 were extracted from SEER. Kaplan-Meier methods and Cox proportional hazard models were used to estimate independent predictors in PNETs patients. Results. - A total of 2637 patients (2147 underwent surgical resection and 490 did not undergo surgery) with histologically confirmed low-grade PNETs in this cohort study. Overall survival (OS) and cancer-specific survival (CSS) of patients with surgery was better than those without surgery (log rank test POS < 0.001, PCSS < 0.001). Multivariate Cox regression analysis showed that surgical status was an independent prognostic factor associated with OS (HR 3.257, 95%CI: 2.635, 4.026) and CSS (HR 3.546, 95%CI: 2.798, 4.493). Subgroup analysis suggested the patients receiving surgery apparently had better OS and CSS regardless of tumor size (all log rank test POS < 0.001, all log rank test PCSS < 0.001) and SEER stage (all log rank test POS < 0.001, all log rank test PCSS < 0.001), compared to patients without removal of the primary tumor. Conclusions. - Surgical resection of primary tumor may have a significant benefit on survival for patients with low-grade nonfunctioning PNETs. To determine the optimal management, grade, stage and tumor size should be considered comprehensively. (c) 2020 L'Auteur(s). Publi ' e par Elsevier Masson SAS. Cet article est publi ' e en Open Access sous licence CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors
    Fitzgerald, Timothy L.
    Mosquera, Catalina
    Vora, Haily S.
    Vohra, Nasreen A.
    Zervos, Emmanuel E.
    AMERICAN SURGEON, 2016, 82 (08) : 737 - 742
  • [2] Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors
    Keutgen, Xavier M.
    Nilubol, Naris
    Glanville, Joanne
    Sadowski, Samira M.
    Liewehr, David J.
    Venzon, David J.
    Steinberg, Seth M.
    Kebebew, Electron
    SURGERY, 2016, 159 (01) : 311 - 318
  • [3] Surgical resection of primary tumor site is associated with prolonged survival in metastatic pancreatic neuroendocrine carcinoma
    Feng, T.
    Ling, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Surgical resection of primary tumor is prolonged survival in metastatic pancreatic neuroendocrine carcinoma
    Feng, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 473 - 473
  • [5] Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors DISCUSSION
    Howe, James R.
    Patel, Dhaval
    Norlen, Olov
    Evans, Douglas
    Demeure, Michael J.
    Patel, Kepal
    SURGERY, 2016, 159 (01) : 318 - 319
  • [6] Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
    Tingting Feng
    Wangxia Lv
    Meiqin Yuan
    Zhong Shi
    Haijun Zhong
    Sunbin Ling
    World Journal of Surgical Oncology, 17
  • [7] Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
    Feng, Tingting
    Lv, Wangxia
    Yuan, Meiqin
    Shi, Zhong
    Zhong, Haijun
    Ling, Sunbin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [8] Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases
    Tao Lianyuan
    Xiu Dianrong
    Sadula, Abuduhaibaier
    Ye Chen
    Chen Qing
    Wang Hanyan
    Zhang Zhipeng
    Zhang Lingfu
    Tao Ming
    Yuan Chunhui
    ONCOTARGET, 2017, 8 (45) : 79785 - 79792
  • [9] Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors
    Toyoda, Junya
    Sahara, Kota
    Tsilimigras, Diamantis, I
    Miyake, Kentaro
    Yabushita, Yasuhiro
    Homma, Yuki
    Kumamoto, Takafumi
    Matsuyama, Ryusei
    Pawlik, Timothy M.
    WORLD JOURNAL OF SURGERY, 2021, 45 (12) : 3643 - 3651
  • [10] Metastatic Pancreatic Neuroendocrine Tumors (pNETs) and Primary Tumor Resection: A NCDB Survival Evaluation
    Westin, G.
    Alsidawi, S.
    Hobday, T.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2017, 105 : 161 - 161